Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott M Wilhelm

Showing results (21-30 of 42) with videos related to

Pageof 5
Sort By:
Archives of Surgery (Chicago, Ill. : 1960)|May 12, 2004
An algorithm to maximize use of minimally invasive parathyroidectomyRoderick M Quiros, Joseph Alioto, Scott M Wilhelm, et al.
Annals of Surgical Oncology|December 25, 2012
Association of thyroid, breast and renal cell cancer: a population-based study of the prevalence of second malignanciesVictoria L Van Fossen, Scott M Wilhelm, Jennifer L Eaton, et al.
Surgery|December 8, 2010
Analysis of the rising incidence of thyroid cancer using the Surveillance, Epidemiology and End Results national cancer data registryJohn D Cramer, Pingfu Fu, Karem C Harth, et al.
American Journal of Surgery|March 29, 2005
Intraoperative parathyroid hormone levels in thyroid surgery are predictive of postoperative hypoparathyroidism and need for vitamin D supplementationRoderick M Quiros, Catherine E Pesce, Scott M Wilhelm, et al.
American Journal of Surgery|December 6, 2022
Varying impact of patient age on the rising rate of pediatric thyroid cancer: Analysis of NCDB database (2004-2017)Heming H Zhao, Cole Pickney, Anuja L Sarode, et al.
Molecular Cancer Therapeutics|October 15, 2008
Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signalingScott M Wilhelm, Lila Adnane, Philippa Newell, et al.
Journal of the National Cancer Institute|March 2, 2006
BAY 43-9006 inhibition of oncogenic RET mutantsFrancesca Carlomagno, Suresh Anaganti, Teresa Guida, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 5, 2007
Sorafenib inhibits imatinib-resistant KIT and platelet-derived growth factor receptor beta gatekeeper mutantsTeresa Guida, Suresh Anaganti, Livia Provitera, et al.
Journal of Surgical Oncology|February 12, 2021
Reassessing the impact of tumor size on operative approach in adrenocortical carcinomaJonathan J Hue, Katherine Bingmer, Heming Zhao, et al.
Surgery|May 7, 2021
Outcomes of malignant pheochromocytoma based on operative approach: A National Cancer Database analysisJonathan J Hue, Christine Alvarado, Katelynn Bachman, et al.
Pageof 5

Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
Archives of Surgery (Chicago, Ill. : 1960)|May 12, 2004
An algorithm to maximize use of minimally invasive parathyroidectomyRoderick M Quiros, Joseph Alioto, Scott M Wilhelm, et al.
Annals of Surgical Oncology|December 25, 2012
Association of thyroid, breast and renal cell cancer: a population-based study of the prevalence of second malignanciesVictoria L Van Fossen, Scott M Wilhelm, Jennifer L Eaton, et al.
Surgery|December 8, 2010
Analysis of the rising incidence of thyroid cancer using the Surveillance, Epidemiology and End Results national cancer data registryJohn D Cramer, Pingfu Fu, Karem C Harth, et al.
American Journal of Surgery|March 29, 2005
Intraoperative parathyroid hormone levels in thyroid surgery are predictive of postoperative hypoparathyroidism and need for vitamin D supplementationRoderick M Quiros, Catherine E Pesce, Scott M Wilhelm, et al.
American Journal of Surgery|December 6, 2022
Varying impact of patient age on the rising rate of pediatric thyroid cancer: Analysis of NCDB database (2004-2017)Heming H Zhao, Cole Pickney, Anuja L Sarode, et al.
Molecular Cancer Therapeutics|October 15, 2008
Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signalingScott M Wilhelm, Lila Adnane, Philippa Newell, et al.
Journal of the National Cancer Institute|March 2, 2006
BAY 43-9006 inhibition of oncogenic RET mutantsFrancesca Carlomagno, Suresh Anaganti, Teresa Guida, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 5, 2007
Sorafenib inhibits imatinib-resistant KIT and platelet-derived growth factor receptor beta gatekeeper mutantsTeresa Guida, Suresh Anaganti, Livia Provitera, et al.
Journal of Surgical Oncology|February 12, 2021
Reassessing the impact of tumor size on operative approach in adrenocortical carcinomaJonathan J Hue, Katherine Bingmer, Heming Zhao, et al.
Surgery|May 7, 2021
Outcomes of malignant pheochromocytoma based on operative approach: A National Cancer Database analysisJonathan J Hue, Christine Alvarado, Katelynn Bachman, et al.
Pageof 5